Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained-release morphine dose-ranging and long-term study for dyspnoea
ACTRN12606000269538Phase 4Not yet recruiting
- Sponsor
- Repatriation General Hospital
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of morphine hydrochloride, sponsored by Repatriation General Hospital. Primary endpoints: Average morning dyspnoea score and Average evening dyspnoea score. Planned start Jul 2006; status: not yet recruiting.
02
Drugs
morphine hydrochloride
Beyond the preview
Go deeper on ACTRN12606000269538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000269538.